Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Switching makes sense if you've plateaued on semaglutide, you're not hitting your blood sugar or metabolic goals, you want the dual-mechanism approach, or you're tolerating semaglutide poorly
Tricare has a two-level appeal process
The SHAPE study, analyzing real-world prescribing data, found: At 3 months: tirzepatide users lost 5.9% of body weight versus 3.6% for semaglutide At 6 months: 10.1% versus 5.8% At 12 months: 15.3% versus 8.3% These are averages from actual patients, not trial participants
Cancer statistics, 2024
US$ 28.67
US$ 28.06
US$ 24.72
US$ 26.28
US$ 20.51
US$ 22.82
US$ 26.30
